2003
DOI: 10.1016/s0014-4827(03)00070-3
|View full text |Cite
|
Sign up to set email alerts
|

Mouse NIPK interacts with ATF4 and affects its transcriptional activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 79 publications
(36 citation statements)
references
References 73 publications
0
36
0
Order By: Relevance
“…Interestingly, the ATF4-CHOP pathway has been previously shown to induce TRB3 expression under conditions of ER stress, and that TRB3 can reciprocally repress the function of ATF4 and CHOP [22,36]. Specifically, Ohoka et al [22] showed that CHOP and ATF4 cooperate to activate the TRB3 promoter.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, the ATF4-CHOP pathway has been previously shown to induce TRB3 expression under conditions of ER stress, and that TRB3 can reciprocally repress the function of ATF4 and CHOP [22,36]. Specifically, Ohoka et al [22] showed that CHOP and ATF4 cooperate to activate the TRB3 promoter.…”
Section: Discussionmentioning
confidence: 99%
“…TRB3 (alias TRIB3, NIPK, SKIP3), a member of the Tribbles family of pseudokinases, interacts with several transcription factors (ATF4 (Bowers et al, 2003;Örd and Örd, 2003), CHOP (Ohoka et al, 2005), NF-κB (Wu et al, 2003), C/EBPβ (Bezy et al, 2007)), protein kinases (Akt/PKB (Du et al, 2003), MAPK kinases MEK1 and MKK7 (Kiss-Toth et al, 2004)) and other proteins (E3 ubiquitin ligase COP1 (Qi et al, 2006), Smad ubiquitin regulatory factor 1 (Chan et al, 2007), nuclear protein CtIP (Xu et al, 2007)), and has been implicated in the regulation of cellular stress response, viability and metabolism. TRB3 has attracted attention for its potential role in medical conditions: molecular and epidemiologic studies, as well as the examination of disease models, have linked TRB3 to insulin resistance (Du et al, 2003;Koo et al, 2004;Prudente et al, 2005;He et al, 2006;Yao and Nyomba, 2008), cardiovascular disease (Prudente et al, 2005) and diabetes (Prudente et al, 2009), and the elevated expression of TRB3 has been reported in many cancer cell lines and primary tumors (Bowers et al, 2003;Xu et al, 2007), and in cancer cells treated with antitumoral agents (Carracedo et al, 2006a,b).…”
Section: Introductionmentioning
confidence: 99%
“…Another example of TRIB-dependent degradation of target proteins in cancer is represented by Activating transcription factor 4 (ATF4) which occurs during hypoxia in human tumour cells overexpressing TRIB3 [28] . Interestingly, the murine ortholog of TRIB3 Neuronal cell death-inducible putative kinase (NIPK) has also been associated with downregulation of ATF4 transcriptional activity, but in absence of proteolytic degradation [29] . The protein interaction of ATF4 with TRIB2 or TRIB1 as not been reported.…”
Section: Trib2: the Ruler Of E3 Ubiquitin Ligase Activitiesmentioning
confidence: 99%